ロード中...
Feasibility of Onchocerciasis Elimination Using a “Test-and-not-treat” Strategy in Loa loa Co-endemic Areas
BACKGROUND: Mass drug administration (MDA) with ivermectin is the main strategy for onchocerciasis elimination. Ivermectin is generally safe, but is associated with serious adverse events in individuals with high Loa loa microfilarial densities (MFD). Therefore, ivermectin MDA is not recommended in...
保存先:
| 出版年: | Clin Infect Dis |
|---|---|
| 主要な著者: | , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2020
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8204788/ https://ncbi.nlm.nih.gov/pubmed/33289025 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciaa1829 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|